CROMA Saypha® Volume Lidocaine 1x1 ml – Cross-Linked Hyaluronic Acid Filler for Deep Volume Restoration and Facial Contouring
CROMA Saypha® Volume Lidocaine 1x1 ml is a cross-linked hyaluronic acid dermal filler developed by CROMA-Pharma GmbH (Austria) for deep dermal and subcutaneous injection.
It restores lost facial volume, enhances contours, and smooths deep wrinkles, providing natural, long-lasting rejuvenation with the added comfort of 0.3% lidocaine to minimize discomfort during treatment.
Product Overview
Part of the CROMA Saypha® professional filler range, Saypha® Volume Lidocaine is specially formulated for volumizing larger facial areas and reshaping contours in patients with moderate to severe volume loss.
The S.M.A.R.T. cross-linking technology ensures a smooth, cohesive gel that integrates naturally with facial tissues for a refined, youthful appearance.
Technology & Composition
Technology: S.M.A.R.T. cross-linking process (Supreme Monophasic and Reticulated Technology) – provides excellent elasticity, uniformity, and long-lasting results.
Composition:
• Cross-linked Hyaluronic Acid (23 mg/ml) – restores structure and volume.
• Lidocaine Hydrochloride (0.3%) – ensures comfort during injection.
• Phosphate buffer (pH 7.1) – maintains stability and biocompatibility.Packaging (Content):
• 1 sterile prefilled syringe of 1 ml
• 2 sterile 27G ½” needles
• Instruction leaflet and traceability labels
• For single-patient use only
Indications & Treatment Areas
Designed for the correction of moderate to severe facial volume loss, Saypha® Volume Lidocaine is ideal for restoring facial harmony and contour.
Recommended Treatment Areas:
Cheeks (for volumization and lift)
Nasolabial folds
Marionette lines
Chin and jawline reshaping
Temples
Clinical Benefits
Restores deep facial volume for balanced, youthful contours
Smooths deep wrinkles and folds while maintaining natural expression
Enhanced patient comfort with lidocaine for painless application
Provides structure and elasticity to aging or sagging skin
Long-lasting effects up to 18 months depending on area and patient factors
Treatment Protocol
Application: Inject into the deep dermis or subcutaneous tissue using linear, fanning, or cross-hatching technique.
Sessions: Usually one session; optional touch-up after 2–4 weeks if needed.
Duration of results: Typically 12–18 months, depending on metabolism, skin type, and injection technique.
Manufacturer & Regulatory Information
Manufactured by CROMA-Pharma GmbH (Austria).
CE-marked Class III Medical Device under EU Regulation (MDR) 2017/745.
ISO 13485 certified manufacturer.
Distributed under compliance with AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) in Spain and the European Union.
For Professional Use Only:
As trusted distributors and providers of aesthetic medicine, Aesthisave® emphasizes that our products are strictly for professional use.
We insist that these treatments be administered only by trained and medically qualified personnel, ensuring the highest standards of safety and patient care.
